AIM To perform a systematic review and meta-analysis on proton pump inhibitors (PPIs)
therapy and the risk of Clostridium difficile infection (CDI). METHODS We conducted a …

OBJECTIVES: Several studies have raised concern regarding the possible association
between proton-pump inhibitors (PPIs) andClostridium difficileinfection (CDI). We aimed to …

Triptolide (TP), a traditional Chinese medicine, has been reported to be effective in the
treatment of autoimmune diseases and exerting antineoplastic activity in several human …

Since publication of the Society for Healthcare Epidemiology of America position paper on
Clostridium difficile infection in 1995, significant changes have occurred in the epidemiology …

Proton-pump inhibitors (PPIs) are a widely prescribed class of medications used to treat acid-
related disorders and use has significantly increased over the last few decades. PPIs are …

OBJECTIVES: Clostridium difficile-associated diarrhea (CDAD) is a major cause of morbidity
and increasing health-care costs among hospitalized patients. Although exposure to …

Aliment Pharmacol Ther 2011; 34: 1269–1281 Summary Background The use of proton
pump inhibitors (PPIs) is increasing worldwide. Suppression of gastric acid alters the …

In the last three decades, Clostridium difficile infection (CDI) has increased in incidence and
severity in many countries worldwide. The increase in CDI incidence has been particularly …

Proton-pump inhibitors (PPIs) remain the leading evidence-based therapy for upper
gastrointestinal disorders, including gastroesophageal reflux disease, dyspepsia, and peptic …

Background. Since 2002, an epidemic of Clostridium difficile–associated-diarrhea (CDAD)
associated with a high case-fatality rate has involved> 30 hospitals in the province of …